Connect Biopharma Holdings Limited (CNTB)
NASDAQ: CNTB · Real-Time Price · USD
2.510
-0.150 (-5.64%)
At close: Jul 10, 2026, 4:00 PM EDT
2.520
+0.010 (0.40%)
After-hours: Jul 10, 2026, 6:46 PM EDT
Connect Biopharma Holdings Employees
Connect Biopharma Holdings had 64 employees as of December 31, 2025. The number of employees increased by 2 or 3.23% compared to the previous year.
Employees
64
Change (1Y)
2
Growth (1Y)
3.23%
Revenue / Employee
$3,641
Profits / Employee
-$1,009,469
Market Cap
158.04M
Employees Chart
Employees History
| Date | Employees | Change (1Y) | Growth (1Y) |
|---|---|---|---|
| Dec 31, 2025 | 64 | 2 | 3.23% |
| Dec 31, 2024 | 62 | -19 | -23.46% |
| Dec 31, 2023 | 81 | -19 | -19.00% |
| Dec 31, 2022 | 100 | -8 | -7.41% |
| Jan 1, 2022 | 108 | 46 | 74.19% |
| Dec 31, 2020 | 62 | - | - |
Related Stocks
| Company Name | Employees |
|---|---|
| Innate Pharma | 164 |
| Pyxis Oncology | 56 |
| OnKure Therapeutics | 45 |
| Milestone Pharmaceuticals | 38 |
| Corbus Pharmaceuticals Holdings | 36 |
| Jyong Biotech | 27 |
| AN2 Therapeutics | 21 |
| Canton Strategic Holdings | 12 |
CNTB News
- 1 day ago - Connect Biopharma initiated with an Outperform at Oppenheimer - TheFly
- 14 days ago - Connect Biopharma initiated with an Overweight at Piper Sandler - TheFly
- 23 days ago - Connect Biopharma Announces Completion of Enrollment of Phase 2 Seabreeze STAT Asthma Study Evaluating Rademikibart for the Treatment of Acute Exacerbations in Asthma - GlobeNewsWire
- 6 weeks ago - Connect Biopharma initiated with a Buy at Canaccord - TheFly
- 7 weeks ago - Connect Biopharma initiated with an Overweight at Cantor Fitzgerald - TheFly
- 7 weeks ago - Connect Biopharma initiated with an Overweight at Cantor Fitzgerald - TheFly
- 7 weeks ago - Connect Biopharma Holdings Transcript: H.C. Wainwright 4th Annual BioConnect Investor Conference - Transcripts
- 2 months ago - Connect Biopharma files to sell 6.13M ordinary shares for holders - TheFly